These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 19160698)

  • 1. Role of molecular markers in diagnosis and prognosis of renal cell carcinoma.
    Requena MJ; Carrasco JC; Alvarez-Kindelan J
    Anal Quant Cytol Histol; 2008 Dec; 30(6):336-7. PubMed ID: 19160698
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal cell carcinoma: molecular and genetic markers as new prognostic and therapeutic tools.
    Filosa A; Fabiani A
    Anal Quant Cytol Histol; 2008 Dec; 30(6):341-3. PubMed ID: 19160702
    [No Abstract]   [Full Text] [Related]  

  • 3. Kidney cancer: When worlds collide--integrating metabolic and transcriptomic data in ccRCC.
    Thoma C
    Nat Rev Urol; 2016 Mar; 13(3):126. PubMed ID: 26813954
    [No Abstract]   [Full Text] [Related]  

  • 4. PLAGL1 (ZAC1/LOT1) Expression in Clear Cell Renal Cell Carcinoma: Correlations with Disease Progression and Unfavorable Prognosis.
    Godlewski J; Krazinski BE; Kowalczyk AE; Kiewisz J; Kiezun J; Kwiatkowski P; Sliwinska-Jewsiewicka A; Maslowski Z; Kmiec Z
    Anticancer Res; 2016 Feb; 36(2):617-24. PubMed ID: 26851016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Possibilities of molecular diagnosis of renal cell carcinoma].
    Junker K
    Aktuelle Urol; 2014 Sep; 45(5):370-3. PubMed ID: 25230022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Future prognostic factors for renal cell carcinoma: Workgroup No. 5. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC).
    Swanson DA; Rothenberg HJ; Boynton AL; Consigliere D; Halling KC; Oda H; Smith D
    Cancer; 1997 Sep; 80(5):997-8. PubMed ID: 9307207
    [No Abstract]   [Full Text] [Related]  

  • 7. Nucleobindin 2 expression is an independent prognostic factor for clear cell renal cell carcinoma.
    Qi C; Ma H; Zhang HT; Gao JD; Xu Y
    Histopathology; 2015 Apr; 66(5):650-7. PubMed ID: 25322808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and validation of TGFBI as a promising prognosis marker of clear cell renal cell carcinoma.
    Lebdai S; Verhoest G; Parikh H; Jacquet SF; Bensalah K; Chautard D; Rioux Leclercq N; Azzouzi AR; Bigot P
    Urol Oncol; 2015 Feb; 33(2):69.e11-8. PubMed ID: 25035170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of amyloid A immunoexpression in the prognosis of renal cell carcinoma.
    Oz Atalay F; Aytac Vuruskan B; Vuruskan H
    APMIS; 2016 Apr; 124(4):257-62. PubMed ID: 26750935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular characterization of metastatic renal cell carcinomas. Differentiation of prognosis and therapy].
    Junker K; Sanjmyatav J; Heinze C; Walter M; Heinzelmann J; Wunderlich H; Schubert J; Steiner T
    Urologe A; 2008 Sep; 47(9):1187-9. PubMed ID: 18688592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD31, EDNRB and TSPAN7 are promising prognostic markers in clear-cell renal cell carcinoma revealed by genome-wide expression analyses of primary tumors and metastases.
    Wuttig D; Zastrow S; Füssel S; Toma MI; Meinhardt M; Kalman K; Junker K; Sanjmyatav J; Boll K; Hackermüller J; Rolle A; Grimm MO; Wirth MP
    Int J Cancer; 2012 Sep; 131(5):E693-704. PubMed ID: 22213152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cell markers aldehyde dehydrogenase type 1 and nestin expressions in renal cell cancer.
    Ozbek E; Calik G; Otunctemur A; Aliskan T; Cakir S; Dursun M; Somay A
    Arch Ital Urol Androl; 2012 Mar; 84(1):7-11. PubMed ID: 22649953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of KIF20A as a tumor biomarker and forwarder of clear cell renal cell carcinoma.
    Xiao W; Chen K; Liang HG; Zhang XP
    Chin Med J (Engl); 2021 Jan; 134(17):2137-2139. PubMed ID: 33410636
    [No Abstract]   [Full Text] [Related]  

  • 14. Expression of parafibromin in clear cell papillary renal cell carcinoma.
    Cui C; Ziober A; Bing Z
    Appl Immunohistochem Mol Morphol; 2013 Jul; 21(4):322-5. PubMed ID: 23060304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 1 and 2 papillary renal cancers are genetically distinct.
    Balakrishnan VS
    Lancet Oncol; 2015 Dec; 16(16):e594. PubMed ID: 26596671
    [No Abstract]   [Full Text] [Related]  

  • 16. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
    Urakami S; Shiina H; Enokida H; Hirata H; Kawamoto K; Kawakami T; Kikuno N; Tanaka Y; Majid S; Nakagawa M; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Dec; 12(23):6989-97. PubMed ID: 17145819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic utility of nestin expression in pediatric tumors in the region of the kidney.
    Murphy AJ; Viero S; Ho M; Thorner PS
    Appl Immunohistochem Mol Morphol; 2009 Dec; 17(6):517-23. PubMed ID: 19417621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epigenetic regulation of urological tumors. Importance for prognosis and metastasis].
    Heinzelmann J; Stubendorff B; Jung V; Baumgart S; Hölters S; Unteregger G; Grimm J; Linxweiler J; Janssen M; Ohlmann CH; Saar M; Siemer S; Stöckle M; Junker K
    Urologe A; 2015 Jun; 54(6):832-8. PubMed ID: 26037021
    [No Abstract]   [Full Text] [Related]  

  • 19. Clear Cell Renal Cell Carcinoma With Borderline Features of Clear Cell Papillary Renal Cell Carcinoma: Combined Morphologic, Immunohistochemical, and Cytogenetic Analysis.
    Williamson SR; Gupta NS; Eble JN; Rogers CG; Michalowski S; Zhang S; Wang M; Grignon DJ; Cheng L
    Am J Surg Pathol; 2015 Nov; 39(11):1502-10. PubMed ID: 26457355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low expression of miR-126 is a prognostic marker for metastatic clear cell renal cell carcinoma.
    Khella HW; Scorilas A; Mozes R; Mirham L; Lianidou E; Krylov SN; Lee JY; Ordon M; Stewart R; Jewett MA; Yousef GM
    Am J Pathol; 2015 Mar; 185(3):693-703. PubMed ID: 25572155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.